Delivery Order SPE2DE24D0021-SPE2D625F2STK
- Not listed
- Fisher Scientific Company L.L.C. was awarded a $1,650 fixed-price delivery order by the Department of Defense's Medical Supply Chain on September 22, 2025, for SOFIA 2 Flu and SARS antigen fluorescent immunoassay supplies. The order, which is a child contract under a larger blanket purchase agreement with the Department of Veterans Affairs, will be fulfilled from Fisher Scientific's Pittsburgh, Pennsylvania facility with an ultimate completion date of November 19, 2025. This is an open...
- Fisher Scientific Company L.L.C., a major federal supplier of laboratory and medical equipment, was awarded a delivery order valued at $5,500 on September 12, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunodiagnostic supplies. This fixed-price delivery order with economic price adjustment provision will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of November 10, 2025. The contract was awarded without a set-aside designation, indicating open competition. The...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,100.00 on June 24, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent testing supplies. This fixed-price contract with economic price adjustment provisions is being performed in Pittsburgh, Pennsylvania, and represents a child contract under a larger vehicle. The award was made by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 20, 2025. No set-aside designation was...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,105.84 for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment was issued on August 7, 2025, with an ultimate completion date of October 3, 2025. The award was made through open competition with no set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, and is funded by the Defense Department's Medical Supply Chain...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $5.5K for SOFIA 2 Flu + SARS Antigen Fluorescent I testing supplies under a fixed-price contract with economic price adjustment provisions. The award, issued on September 3, 2025, by the Medical Supply Chain, a defense-focused component within the federal government, is scheduled for completion by October 30, 2025, with performance taking place in Pittsburgh, PA. This delivery order represents a child contract,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,658.76 on August 8, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment serves the Medical Supply Chain, a defense-oriented federal agency, with performance to be completed by October 6, 2025, at Fisher Scientific's Pittsburgh, Pennsylvania facility. The contract represents a child award under a larger vehicle and carries no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,200 for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent testing supplies. The award, issued on September 15, 2025, is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of November 12, 2025. The contract will be performed in Pittsburgh, Pennsylvania, and was funded through the Department of Defense's Medical Supply Chain division. No set-aside designation was...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300 for SOFIA 2 Flu + SARS antigen fluorescent diagnostic supplies by the Medical Supply Chain, a defense-focused federal agency, with an award date of September 4, 2025 and ultimate completion by October 31, 2025. The contract employs fixed-price pricing with economic price adjustment and carries no set-aside designation, reflecting open competition procurement. Performance will take place at Fisher Scientific's...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,211.68 for SOFIA 2 Flu + SARS Antigen Fluorescent reagents under a fixed-price contract with economic price adjustment provisions. The award, issued on August 1, 2025, is classified as a child contract with an ultimate completion date of September 29, 2025. The place of performance is Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, reflecting Fisher Scientific's competitive...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract on August 14, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies with a ceiling value of $4,400. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by October 10, 2025, and will be performed in Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, reflecting Fisher Scientific's...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F2STKDelivery Order
Fisher Scientific Company L.L.C. was awarded a $2.2K delivery order for SOFIA 2 Flu + SARS Antigen Fluorescent immunoassay supplies on September 5, 2025, with an ultimate completion date of November 3, 2025. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain, a defense-focused federal agency, with performance at Fisher Scientific's Pittsburgh, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting the contractor's established capability to compete for federal procurements. As a child contract, this delivery order likely represents an individual task order issued under a parent blanket purchase agreement or multiple award schedule. Fisher Scientific Company L.L.C., a major supplier of laboratory supplies, scientific instruments, and specialized testing solutions, brings substantial federal contracting experience to this engagement. The company, registered in the System for Award Management since July 3, 2001, has extensive relationships with agencies including the National Institutes of Health, Department of Veterans Affairs, and the Food and Drug Administration. The SOFIA 2 diagnostic supplies support rapid antigen testing capabilities for influenza and SARS-CoV-2 detection, providing critical diagnostic materials to support federal medical supply chain operations and defense-related healthcare initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/5/25 |